MeSH D006223 - multiple hamartoma syndrome
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D009378:Multiple primary neoplasms
0 Companies
0 Drugs
Success rate
D006222:Hamartoma
0 Companies
0 Drugs
Success rate
D009386:Hereditary neoplastic syndromes
0 Companies
0 Drugs
Success rate
D006223:
Multiple hamartoma syndrome
0 Companies
0 Drugs
Success rate
D016715:Proteus syndrome
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
50%1/2
Phase 2
14%1/7
Phase 3
0%0/0
Approved: 0Overall Success rate: 0%
All Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use